SHEIKHA HEMOLYTIC ANEMIAS. SHEIKHA Abnormalities of the Environment of the Red Cells Abnormalities of the Red Cells Premature destruction of the red cells.

Slides:



Advertisements
Similar presentations
Normocytic Anemia David Lee, MD, FRCPC. Normocytic anemia a heterogenous group of anemias normocytosis implies normal DNA metabolism and hemoglobin synthesis.
Advertisements

Approach to Anemia - Summary
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
Lecturer /Sulaimani College of Medicine/ Dept.of Pathology
In the name of GOD.
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Enzymopathies = ENZYME DEFECTS
Life of a Red Blood Cell Erythroid precursors undergo 4-5 divisions in marrow, extrude nucleus, become reticulocytes, enter peripheral blood, and survive.
HEMOLYTIC ANEMIA HOSEA NJOKU 1405.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
increase red cell destruction = reduced red-cell life span
HEMOLYTIC ANEMIAS. HEMOLYTIC ANEMIA Anemia of increased destruction –Normochromic, normochromic anemia –Shortened RBC survival –Reticulocytosis - Response.
 Charachterized by:  A nemia results when the rate of destruction exceeds the capacity of the m arrow to produce RBCs(The bone marro 8 times increased.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Outcome : The student will know : -The types of hemolytic anemias.
Week 2: Hemolytic Anemia
Introduction to Hemolytic Anemias
MLAB 1415-Hematology Keri Brophy-Martinez
Classification of Hemolytic anemias I. Red cell abnormality (Intracorpuscular factors) A. Hereditary 1. Membrane defect (spherocytosis, elliptocytosis)
Anaemia By Jeeves.
Glucose-6-phosphate Dehydration Deficiency Nada Mohamed Ahmed, MD, MT (ASCP)i.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof
HEREDITARY/ACQUIRED HEMOLYTIC ANEMIA
Hemolytic Anemias Defined as those anemias result from an increased in the rate of red cell destruction. The red cell destruction is usually removed extravascular.
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
Hemolytic anemia Excessive destruction of red cells Acute Hemolytic anemia Chronic Hemolytic anemia Congenita l Acquired : Immune Non-immune.
Haemolytic anaemias Dr. Suhair Abbas Ahmed.
Anemia Kristine Krafts, M.D.. Background facts about blood Anemia: general information Anemia: specific types Anemia Outline.
Laboratory evaluation of erythrocyte RBC Haemoglobin Packed cell volume MCV MCH MCHC RDW Reticulocyte Blood film Quantitative description of erythropoiesis.
Acquired haemolytic anaemias
Auto Immune hemolytic anemia
Hemolytic anemias.
MLAB 1415-Hematology Keri Brophy-Martinez Hemolytic Anemias: Enzyme Deficiencies.
Hereditary Haemolytic Anaemias
HEMOLYTIC ANEMIAS.
Inherited and acquired haemolytic anaemias
CLASSIFICATION OF ANEMIA
Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red cells (reticulocytes)
HEMOLYTIC DESORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red.
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 18: Hemolytic Anemia: Nonimmune Defects.
Glucose-6-phosphate Dehydration Deficiency
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
Red cell membrane defects. Hereditary spherocytosis (HS) The most common of the inherited RBC membrane defects, affecting 1 in 5000 individuals. The disorder.
Anemia Presented by M.A. Kaeser, DC Fall 2009
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
Done by : Bara Shayib Supervised by : Dr. Abdullateef Alkhateeb.
HEMOLYTIC ANEMIA Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin.
HAEMOLYTIC ANAEMIA HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam.
Acquired Hemolytic Anemias
HEMOLYTIC ANEMIA INCREASE RED CELL DESTRUCTION =
Hemolytic Anemias Definitions and Classification of Hemolytic Anemias
Chapter 13 Lesson 13.2 anemia Aplastic anemia Hemolytic anemia Pernicious anemia sickle cell thalassemia Hemochromatosis polycythemia vera Hemophilia purpura.
and BLEEDING DISORDERS
Jaundice: Causes and Etiopathogenesis
MLAB Hematology Fall 2007 Keri Brophy-Martinez
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
MLAB 1415: Hematology Keri Brophy-Martinez
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Red cell membrane defects
HEMOLYTIC DISORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new.
HEMOLYTIC ANEMIA Dr Ramadas Nayak
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
溶血性贫血 Hemolytic Anemia
MLAB 1415-Hematology Keri Brophy-Martinez
Hemolytic anemias (1 of 2)
CLASSIFICATION OF ANEMIAS
Approach to Haemolysis
CONSULTANT HAEMATOLOGIST DEPARTMENT OF PATHOLOGY
Anemia in Adults: A Contemporary Approach to Diagnosis
Presentation transcript:

SHEIKHA HEMOLYTIC ANEMIAS

SHEIKHA Abnormalities of the Environment of the Red Cells Abnormalities of the Red Cells Premature destruction of the red cells

HEMOLYTIC ANEMIAS SHEIKHA Abnormalities of the Red Cells

HEMOLYTIC ANEMIAS SHEIKHA Membrane Hb Enzymes 120 days

HEMOLYTIC ANEMIAS SHEIKHA Membrane Hb Enzymes HS HE H. Stomatocytosis

HEMOLYTIC ANEMIAS SHEIKHA Membrane Hb Enzymes HS HE H.St. Hemoglobinopathies Thalassemia Sickle

HEMOLYTIC ANEMIAS SHEIKHA Membrane Hb Enzymes HS HE H.St. Hemoglobinopathies Thalassemia Sickle G6PDH ↓ PK ↓ ALL CONGENITAL

HEMOLYTIC ANEMIAS SHEIKHA PNH Paroxysmal Nocturnal Hemoglobinuria ACQUIRED

HEMOLYTIC ANEMIAS SHEIKHA Abnormalities of the Environment of the Red Cells

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Plasma Constituents IMMUNE: DRUGS HDN TOXINS Drugs AIHA Abnormal Physical Environment Fragmentation Hypersplenism Burn SHEIKHA WARMCHAD Infections Malaria Cl. Welchii

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Plasma Constituents IMMUNE: DRUGS HDN TOXINS Drugs AIHA SHEIKHA WARMCHAD

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Plasma Constituents IMMUNE: HDN Drugs AIHA SHEIKHA WARMCHAD IMMUNE HEMOLYTIC ANEMIAS

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Plasma Constituents IMMUNE: DRUGS HDN TOXINS Drugs AIHA SHEIKHA WARMCHAD AIHA WARM IDIOPATHIC Associated with: SLE CLL LYMPHOMA OTHER AUOIMMUNE DISORDERS MISCELANEOUS

HEMOLYTIC ANEMIAS SHEIKHA Coomb’s Test

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Plasma Constituents IMMUNE: DRUGS HDN TOXINS Drugs AIHA SHEIKHA WARMCHAD AIHA CHAD ACUTE CHRONIC ATYPICAL MYCO- PLASMA PNEMONIA IM IDIO- PATHIC LYMPH- OMA

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Plasma Constituents IMMUNE: DRUGS HDN TOXINS Drugs AIHA SHEIKHA WARMCHAD AIHA WARMCHAD PCH ACUTE Measles Mumps Flu Idiopathic CHRONIC Idiopathic

Management of AIHA STEROID SPLENECTOMY RITUXIMAB CYCLOSPORIN FOLATE

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Physical Environment Fragmentation Hypersplenism Burn SHEIKHA March Hb-uria Abnormal Blood Vessels MAHA Microangiopathic Hemolytic Anemia TTP/ HUS Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome Mechanical HA From damaged Valves Malignancy “Mucin Secreting Adeno- Carcinoma” Septicemia Malignant HTN

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT SHEIKHA Infections Malaria Cl. Welchii

HEMOLYTIC ANEMIAS due to ABNORMAL RBC ENVIRONMENT Abnormal Plasma Constituents IMMUNE: DRUGS HDN TOXINS Drugs AIHA Abnormal Physical Environment Fragmentation Hypersplenism Burn SHEIKHA WARMCHAD Infections Malaria Cl. Welchii

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS LABORATORY FINDINGS: Hyperbilirubinemia “mild & unconjugated” Anemia Increased Urinary Urobilinogen Reduced Haptoglobin Reticulocytosis & Polychromasia Increased Marrow Activity RBC shape changes: Spherocytosis Fragmentation SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA CLINICAL FEATURES Jaundice “usually mild” Pallor Acholuric jaundice Splenomegaly Gall stones Leg ulcers Crises: Aplastic Hemolytic Sequestration

HEMOLYTIC ANEMIAS SHEIKHA LABORATORY FINDINGS: Hyperbilirubinemia Anemia Increased Urinary Urobilinogen Reduced Haptoglobin Reticulocytosis & Polychromasia Increased Marrow Activity RBC shape changes CLINICAL FEATURES Jaundice “usually mild” Pallor Acholuric jaundice Splenomegaly Gall stones Leg ulcers

HEMOLYTIC ANEMIAS SHEIKHA Intravascular Hemolysis HemoglobinemiaHemoglobinuria Hemosiderinuria

HEMOLYTIC ANEMIAS SHEIKHA Hemoglobinuria

HEMOLYTIC ANEMIAS SHEIKHA Hemosiderinuria

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA Hereditary Spherocytosis

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA Hereditary Elliptocytosis

MANAGEMENT OF HS SPLENECTOMY OPSI PNEUMOVAX Hib Folate

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA Glucose 6 Phosphate Dehydrogenase Deficiency

HEMOLYTIC ANEMIAS SHEIKHA Glucose 6 Phosphate Dehydrogenase Deficiency Sex-linked 200 million Middle East Mediterranean Africa Saudis13% Kurds40% Suly Study 6% Malaria protection

SHEIKHA G-6-P F-6-P F 1,6 DP DHAP Ga3P 1,3 DPG 3 PG 2 PG PEP LactatePyruvate Glucose Glycolysis Embden-Meyerhof Pathway

SHEIKHA G-6-P F-6-P F 1,6 DP DHAP Ga3P 1,3 DPG 3 PG 2 PG PEP LactatePyruvate Glucose Glycolysis ATP ADP ATP ADP OXIDATIVE DAMAGE

SHEIKHA G-6-P F-6-P F 1,6 DP DHAP Ga3P 1,3 DPG 3 PG 2 PG PEP LactatePyruvate 6PGRu5P NADP NADP H * Glucose NADPNADPH * OXIDATIVE DAMAGE G6PDH PPP

SHEIKHA G-6-P F-6-P F 1,6 DP DHAP Ga3P 1,3 DPG 3 PG 2 PG PEP LactatePyruvate 6PGRu5P NADP NADP H * Glucose NADPNADPH * G6PDH A- Mediterranean 10% of Blacks 10% Activity

HEMOLYTIC ANEMIAS SHEIKHA Glucose 6 Phosphate Dehydrogenase Deficiency Favism Highly Palatable Easily Cultivated Staple Food in G6PDH areas High Protein High Nutritional Value

HEMOLYTIC ANEMIAS SHEIKHA Glucose 6 Phosphate Dehydrogenase Deficiency Favism Specific to Fava beans Peas & others are safe Erratic Only in 25% of G6PDH Deficient Patients Same Patient “Only Occasionally” Dosage “Children” Bean Maturity Food Processing

HEMOLYTIC ANEMIAS SHEIKHA Acute drug-induced hemolysis Favism Chronic hereditary non- Spherocytic Anemia Neonatal jaundice Glucose 6 Phosphate Dehydrogenase Deficiency

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

G-6-P F-6-P F 1,6 DP DHAP Ga3P 1,3 DPG 3 PG 2 PG PEP LactatePyruvate Glucose 2,3 DPG PK PK Deficiency

SHEIKHA Drugs and Chemicals Associated with Hemolysis in G6PDH-Deficient Subjects DrugsDefinite AssociationPossible AssociationDoubtful Association AntimalarialsPrimaquineChloroquineQuinacrine Pamaquine--Quinine SulfonamidesSulfanilamideSulfadimidineSulfoxone SulfacetamideSulfasalazineSulfadiazine SulfapyridineGlyburideSulfisoxalone Sulfamethoxazole-- SulfonesDapsone-- NitrofuransNitrofurantoin-- Antipyretic/analgesicAcetanilidAspirinAcetaminophen -- Phenacetin

SHEIKHA DrugsDefinite Association Possible Association Doubtful Association Other drugsNalidixic acidCiprofloxacinPAS NiridazoleChloramphenicolDoxorubicin Methylene blueVitamin K analogsProbenecid PhenazopyridineAscorbic acidDimercaprol SeptrinPAS-- Other chemicalsNaphthaleneAcalypha indica-- Trinitrotoluene-- Drugs and Chemicals Associated with Hemolysis in G6PDH-Deficient Subjects

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA

HEMOLYTIC ANEMIAS SHEIKHA